Summary:Purpose: Despite use of the ketogenic diet (KD) for >75 years its effectiveness or mechanism of action has been examined in few animal studies. Using the kindling model of epilepsy, we tested the anticonvulsant effectiveness and behavioral consequences of an experimental KD in adult rats.Methods: Rats fully kindled from the amygdala were divided into KD-fed or standard rat diet-fed groups; diet treatment continued for 5 weeks. The KD approximated at 4:l ("classic") ketogenic diet and consisted (by weight) of 70% fat, 14% protein, no carbohydrate, and appropriate vitamins, minerals and fiber; 92% of energy provided was contributed by fat and 8% was contributed by protein. Afterdischarge threshold and duration (ADT, ADD) and stage 5 seizure threshold and duration (ST, SD) were assessed weekly for 5 weeks. During week 3, learning and memory were tested by the water maze and the behavioral response to a novel environment was assessed by the open field test.Results: Rats receiving the KD became ketonemic and had weight gains similar to those of control rats. As compared with rats receiving a standard diet, those fed the KD had an elevated ADT and ST for the first 2 weeks of treatment. The control and KD-fed groups did not differ with regard to ADD or SD at any time during the study, and both groups performed similarly in the water maze and open field test.Conclusions: In the kindling model, the KD afforded transient protection against the focal generation of kindled seizures but not seizure spread. Rats that received the KD did not perform differently from control-fed rats on spatial learning or exploratory behavior tasks. Our results provide a promising model for study of the anticonvulsant mechanisms of ketosis. Key Words: Ketogenic diet-Kindling-Seizure-Afterdischarge threshold-Water maze.The ketogenic diet (KD) is a high-fat, low-carbohydrate diet that has been used for treatment of refi-actory seizures for >75 years (1). Nevertheless, information on the optimal formulation of the diet, the seizure types in which it might be most effective, and the characteristics of patients who might benefit from its use is limited (2,3). Despite extensive clinical use of the KD, surprisingly few investigators have attempted to determine how and even whether the KD works (3,4). Furthermore, although anecdotal reports cite improved cognition and alertness in patients receiving the KD (5,6), this claim has not been evaluated in any well-controlled clinical or experimental studies.The KD was used widely before antiepileptic drugs (AEDs) became available, but since the advent of modern pharmacological therapy, the KD has largely been paring and maintaining a patient on the KD is often a daunting challenge for both family and physician. Recently, however, there has been a resurgence of interest in the KD (2,7), which has given impetus to efforts designed to verify experimentally the effectiveness and optimal indications of this increasingly popular but unconventional therapy.Animal models offer several advantages for investi...